Ju Wenju

Title: Innovations in Chronic Kidney Disease Prediction by Ju Wenju

Introduction

Ju Wenju is an accomplished inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of chronic kidney disease (CKD) through his innovative research and patent work. His expertise lies in identifying biomarkers that can predict the progression of CKD, which is crucial for improving patient outcomes.

Latest Patents

Ju Wenju holds a patent for "Biomarkers and methods for progression prediction for chronic kidney disease." This patent focuses on biomarkers and methods for identifying an increased risk of CKD progression or for monitoring CKD therapy. The invention involves detecting the levels of one or more of NTpro BNP, EGF, Apo H, GDF-15, and the albumin-to-creatinine ratio. This innovative approach has the potential to enhance the management of chronic kidney disease.

Career Highlights

Ju Wenju is affiliated with the University of Michigan, where he conducts his research and develops his inventions. His work has garnered attention for its potential impact on healthcare, particularly in the area of kidney disease management. With a total of 1 patent, he continues to contribute to advancements in medical science.

Collaborations

Ju Wenju has collaborated with notable colleagues, including Guillemette Duchateau-Nguyen and Corinne Solier. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the quality of his research.

Conclusion

Ju Wenju's innovative work in the field of chronic kidney disease prediction exemplifies the importance of research and invention in healthcare. His contributions are paving the way for improved patient care and outcomes in the management of CKD.